A 64-year-old male with a history of type 2 diabetes mellitus and stage 3 chronic kidney disease (CKD) presents for a routine follow-up. He reports a two-month history of progressive fatigue, shortness of breath on exertion, and decreased exercise tolerance. He denies any dark stools, hematuria, or unusual dietary habits. His medications include metformin, lisinopril, empagliflozin, and atorvastatin. Physical examination is notable for conjunctival pallor and a flow murmur at the left upper sternal border.
Laboratory studies show:
Hemoglobin: 8.8 g/dL
Mean corpuscular volume (MCV): 88 fL
Reticulocyte count: 0.8% (corrected: 0.5%)
Serum ferritin: 250 ng/mL
Transferrin saturation: 25%
Serum creatinine: 2.4 mg/dL (Estimated GFR: 34 mL/min/1.73 m2)
Which of the following is the most likely primary mechanism for this patient's anemia?
The correct answer is:
B) Deficient erythropoietin production
This patient has anemia due to chronic kidney disease (CKD). The kidneys are the primary site of erythropoietin (EPO) production, specifically by the peritubular interstitial cells in the renal cortex. As CKD progresses (typically when GFR falls below 60 mL/min), the renal mass decreases, leading to a deficiency in EPO. This results in a normocytic, normochromic anemia with a low reticulocyte count (underproduction anemia), as there is insufficient stimulation of the bone marrow to produce new red blood cells.
Answer choice A: Chronic gastrointestinal blood loss, is incorrect. While patients with diabetes may have gastrointestinal issues or take aspirin, blood loss typically presents as a microcytic anemia (low MCV) with low ferritin due to iron deficiency. This patient has a normocytic anemia and a normal ferritin level, making blood loss less likely than EPO deficiency.
Answer choice C: Iron malabsorption in the duodenum, is incorrect. Malabsorption usually presents with iron deficiency (low ferritin and low transferrin saturation). In CKD, the inflammatory state can increase hepcidin, which inhibits iron release, but the primary driver of anemia in chronic kidney disease is the lack of the EPO signal itself.
Answer choice D: Reduced red blood cell lifespan, is incorrect. While the uremic environment in advanced chronic kidney disease can slightly shorten the lifespan of red blood cells, this is a minor contributing factor compared to the profound lack of erythropoiesis caused by EPO deficiency.
Answer choice E: Vitamin B12 deficiency secondary to metformin, is incorrect. Long-term metformin use can interfere with vitamin B12 absorption in the terminal ileum, leading to deficiency. However, B12 deficiency causes a macrocytic anemia (MCV > 100 fL) with hypersegmented neutrophils, which does not match this patient's normocytic indices.
Key Learning Point
Anemia due to chronic kidney disease is a classic normocytic, normochromic anemia characterized by a low reticulocyte count. The primary pathophysiology is the decreased production of erythropoietin by the kidneys. Management typically involves the administration of erythropoiesis-stimulating agents (ESAs), provided that iron stores (ferritin and transferrin saturation) are adequate to support the resulting increase in red cell production.
